Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) traded up 9.6% on Wednesday . The company traded as high as $3.26 and last traded at $3.21. 1,427,869 shares traded hands during trading, a decline of 63% from the average session volume of 3,826,041 shares. The stock had previously closed at $2.93. Lexicon Pharmaceuticals Stock Performance […]
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) had its price target dropped by equities researchers at Citigroup from $8.00 to $5.00 in a report issued on Friday, FlyOnTheWall reports. Citigroup’s price target would suggest a potential upside of 167.38% from the stock’s current price. Separately, StockNews.com raised Lexicon Pharmaceuticals to a “sell” rating in a […]
StockNews.com upgraded shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Rating) to a sell rating in a report released on Tuesday. Several other research analysts have also recently issued reports on the company. Jefferies Financial Group began coverage on Lexicon Pharmaceuticals in a research report on Tuesday, March 7th. They issued a hold rating and a […]